Atea Pharmaceuticals Inc share price logo

Atea Pharmaceuticals Inc Share Price

NASDAQ: AVIR

Small Cap

$3.13

-0.17

(-5.15%)

as on

Atea Pharmaceuticals Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $3.1
    $3.27
    downward going graph

    0.96%

    Downside

    4.47%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.46
    $4.15
    downward going graph

    21.57%

    Downside

    32.43%

    Upside

    downward going graph

Atea Pharmaceuticals Inc share price movements today

Previous Close
$3.30
Open
$3.25
Volume
377.4K
Day's Low - High
$3.1 - $3.27
52 Week Low - High
$2.46 - $4.15

Atea Pharmaceuticals Inc Historical Returns

1 Month Return
-10.29 %
3 Month Return
-0.63 %
1 Year Return
-18.86 %
3 Year Return
-56.21 %
5 Year Return
0 %

Atea Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Atea Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$261.9M

EPS (TTM)

-1.635

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.64%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-145.0M

Revenue (TTM)

192.2M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Atea Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atea Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Atea Pharmaceuticals Inc image
Atea Pharmaceuticals Inc
SELL$261.9MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B280.5%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.2B54.04%28.0831.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Atea Pharmaceuticals Inc Stock including INR - Dollar returns

The Atea Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Atea Pharmaceuticals Inc investment value today

Current value as on today

₹86,018

Returns

₹13,982

(-13.98%)

Returns from Atea Pharmaceuticals Inc Stock

₹19,121 (-19.12%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Atea Pharmaceuticals Inc Stock

Based on 9 analysts

SELL

11.11%

Buy

33.33%

Hold

55.56%

Sell

Based on 9 analysts, 55.56% of analysts recommend a 'SELL' rating for Atea Pharmaceuticals Inc. Average target price of $7.5

Atea Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Atea Pharmaceuticals Inc.

What analysts predicted

58.27%UPSIDE

Target Price

$7.5

Current Price

$3.13

Analyzed by

9 Analysts

Target

$7.50

Atea Pharmaceuticals Inc target price $7.5, a slight upside of 58.27% compared to current price of $3.13. According to 9 analysts rating.

Atea Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Atea Pharmaceuticals Inc Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Atea Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-41
-35
-40
-46
-69
-46
-37
-39
-39
-41
EBITDA
-41
-35
-40
-38
-69
-46
-37
-33
-39
-41
Interest Expense
6
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-35
-27
-32
-38
-62
-40
-30
-33
-34
-36
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-35
-28
-33
-39
-63
-40
-31
-33
-34
-37
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-8063.22%
0.00%
0.00%

Atea Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
48
351
192
-
-
Gross Profit
0
0
48
351
0
-70
0
Operating Income
-9
-14
-11
138
-130
-164
-192
EBITDA
-9
-14
-11
138
-130
-119
-167
Interest Expense
-
-
0
0
11
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-9
-14
-10
138
-119
-134
-167
Income Tax Expense
0
0
0
17
-3
1
0
Net Income
-9
-13
-10
121
-115
-135
-168
Net Profit Margin
0.00%
0.00%
-22.51%
34.49%
-60.31%
0.00%
0.00%

Atea Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-28
-33
-39
-63
-40
-31
-33
-34
-37
Operating Cash Flow
-16
-17
-21
-39
-42
-23
-30
-30
-32
Investing Cash Flow
46
-58
27
56
124
-122
-3
85
15
Financing Cash Flow
-
0
-
0
-
0
-
0
-14
Change in Cash
30
-76
5
17
82
-144
-33
54
-31

Atea Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-14
-10
121
-115
-135
-168
Operating Cash Flow
-12
296
-87
-120
-85
-135
Investing Cash Flow
0
0
0
-455
40
56
Financing Cash Flow
0
531
1
0
0
0
Change in Cash
-12
828
-85
-576
-44
-79

Global Institutional Holdings in Atea Pharmaceuticals Inc

Funds
Holdings
BlackRock Inc
11.02%
BML Capital Management LLC
9.38%
FMR Inc
7.42%
TANG CAPITAL MANAGEMENT LLC
5.92%
Vanguard Group Inc
5.83%
See all

Atea Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 02 September

    Tue, 04:30 PM

    -

    Atea Pharmaceuticals to participate in Morgan Stanley Healthcare Conference on September 9, 2025.

Insights on Atea Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 94.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 177.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AVIR stock has moved down by -10.4%

About Atea Pharmaceuticals Inc

atea pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. the company's lead product candidate is at-527, a novel antiviral agent for the treatment of patients infected with severe acute respiratory syndrome coronavirus 2 and is under phase 3 clinical trial. it also develops at-787 which is under phase 2 clinical for the treatment of hepatitis c virus; at-752 which is under phase 2 clinical trial for the treatment of dengue; and at-889, at-934, and other product candidates for the treatment of respiratory syncytial virus are under phase 2 clinical trials. the company was incorporated in 2012 and is based in boston, massachusetts.
OrganisationAtea Pharmaceuticals Inc
Headquarters225 Franklin Street, Boston, MA, United States, 02110
IndustryHealth Technology
CEODr. Jean-Pierre Sommadossi Ph.D.
E-voting on sharesClick here to vote

Key Management of Atea Pharmaceuticals Inc

Name

Title

Ms. Andrea J. Corcoran J.D.

CFO, Executive VP of Legal & Secretary

Mr. John F. Vavricka

Chief Commercial Officer

Dr. Janet M. J. Hammond M.D., Ph.D.

Chief Development Officer

Mr. Wayne Foster CPA

Executive VP of Finance & Chief Accounting Officer

Mr. Adel Moussa Ph.D.

Executive Vice President of Chemistry

Mr. Xiao-Jian Zhou Ph.D.

Executive Vice President of Early Stage Development

Dr. Jean-Pierre Sommadossi Ph.D.

Founder, Chairman, CEO & President

Dr. Maria Arantxa Horga M.D.

Chief Medical Officer

Ms. Jonae R. Barnes

Senior Vice President of Investor Relations & Corporate Communications

Mr. Keith Pietropaolo

Executive VP of Clinical Sciences & Project Management

FAQs

What is Atea Pharmaceuticals Inc share price today?

Atea Pharmaceuticals Inc share price today is $3.13 as on at the close of the market. Atea Pharmaceuticals Inc share today touched a day high of $3.27 and a low of $3.1.

What is the 52 week high and 52 week low for Atea Pharmaceuticals Inc share?

Atea Pharmaceuticals Inc share touched a 52 week high of $4.15 on and a 52 week low of $2.46 on . Atea Pharmaceuticals Inc stock price today i.e. is closed at $3.13,which is 24.49% down from its 52 week high and 27.49% up from its 52 week low.

What is Atea Pharmaceuticals Inc's market capitalisation today?

Atea Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Atea Pharmaceuticals Inc Stock (AVIR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atea Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atea Pharmaceuticals Inc Shares that will get you 0.4792 shares as per Atea Pharmaceuticals Inc share price of $3.13 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Atea Pharmaceuticals Inc Stock (AVIR) from India?

Indian investors can start investing in Atea Pharmaceuticals Inc (AVIR) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Atea Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Atea Pharmaceuticals Inc share’s latest price of $3.13 as on September 13, 2025 at 1:29 am IST, you will get 3.1949 shares of Atea Pharmaceuticals Inc. Learn more about fractional shares .